Statements (49)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Radiotherapy technique
|
gptkbp:administeredOver |
Several days or weeks
|
gptkbp:alternativeTo |
Surgery
Chemotherapy Single-fraction radiotherapy |
gptkbp:appliesTo |
Brain tumors
Head and neck cancers Prostate cancer Breast cancer Solid tumors |
gptkbp:benefit |
Allows normal tissue repair
Improves therapeutic ratio |
gptkbp:contraindication |
gptkb:Pregnancy
Severe comorbidities |
gptkbp:contrastsWith |
Single-dose radiotherapy
|
gptkbp:deliveredBy |
Linear accelerator
Cobalt-60 machine |
gptkbp:developedBy |
Henri Coutard
|
gptkbp:doseUnit |
gptkb:Gray_(Gy)
|
gptkbp:fractionSize |
1.8-2 Gy per fraction (conventional)
|
gptkbp:goal |
Maximize tumor dose
Minimize normal tissue exposure |
https://www.w3.org/2000/01/rdf-schema#label |
Fractionated radiotherapy
|
gptkbp:introducedIn |
1920s
|
gptkbp:method |
Divides total radiation dose into multiple smaller doses
|
gptkbp:monitors |
Medical physicist
Radiation oncologist Radiation therapist |
gptkbp:purpose |
Increase tumor control
Reduce side effects |
gptkbp:regulates |
Radiation oncology guidelines
|
gptkbp:relatedTo |
Conformal radiotherapy
Intensity-modulated radiotherapy Stereotactic radiotherapy |
gptkbp:requires |
Imaging studies
Treatment planning |
gptkbp:reviewedBy |
gptkb:National_Comprehensive_Cancer_Network
gptkb:American_Society_for_Radiation_Oncology |
gptkbp:sideEffect |
gptkb:Nausea
Fatigue Hair loss Skin irritation |
gptkbp:subspecies |
Accelerated fractionation
Hyperfractionation Hypofractionation |
gptkbp:totalDose |
Varies by cancer type
|
gptkbp:usedIn |
Cancer treatment
|
gptkbp:bfsParent |
gptkb:Biological_Effective_Dose
|
gptkbp:bfsLayer |
7
|